A detailed history of Hyman Charles D transactions in Stryker Corp stock. As of the latest transaction made, Hyman Charles D holds 4,412 shares of SYK stock, worth $1.71 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,412
Previous 4,417 0.11%
Holding current value
$1.71 Million
Previous $1.58 Million 5.0%
% of portfolio
0.08%
Previous 0.09%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$324.3 - $354.67 $1,621 - $1,773
-5 Reduced 0.11%
4,412 $1.5 Million
Q3 2022

Nov 09, 2022

BUY
$189.27 - $231.83 $3,028 - $3,709
16 Added 0.36%
4,417 $895,000
Q3 2021

Nov 09, 2021

SELL
$248.9 - $280.09 $34,846 - $39,212
-140 Reduced 3.08%
4,401 $1.16 Million
Q4 2020

Feb 08, 2021

SELL
$202.01 - $245.04 $376,950 - $457,244
-1,866 Reduced 29.12%
4,541 $1.11 Million
Q3 2020

Oct 26, 2020

SELL
$177.77 - $215.81 $3,910 - $4,747
-22 Reduced 0.34%
6,407 $1.34 Million
Q2 2020

Aug 06, 2020

BUY
$144.67 - $207.03 $3,182 - $4,554
22 Added 0.34%
6,429 $1.16 Million
Q1 2020

Apr 30, 2020

SELL
$126.5 - $225.1 $2,656 - $4,727
-21 Reduced 0.33%
6,407 $1.07 Million
Q4 2019

Feb 03, 2020

BUY
$197.98 - $220.53 $13,264 - $14,775
67 Added 1.05%
6,428 $1.35 Million
Q2 2019

Jul 24, 2019

BUY
$180.24 - $205.58 $3,604 - $4,111
20 Added 0.32%
6,361 $1.31 Million
Q1 2019

May 13, 2019

BUY
$152.46 - $198.0 $135,232 - $175,626
887 Added 16.26%
6,341 $1.25 Million
Q3 2018

Nov 14, 2018

BUY
$163.25 - $177.68 $18,773 - $20,433
115 Added 2.15%
5,454 $969,000
Q1 2018

May 07, 2018

SELL
$148.01 - $168.91 $7,400 - $8,445
-50 Reduced 0.93%
5,339 $859,000
Q3 2017

Nov 13, 2017

BUY
$138.36 - $147.87 $4,842 - $5,175
35 Added 0.65%
5,389 $765,000
Q2 2017

Aug 14, 2017

BUY
N/A
5,354
5,354 $743,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $147B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Hyman Charles D Portfolio

Follow Hyman Charles D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.